Valuation: Illumina, Inc.

Market Cap 3.62TCr 3.16TCr 2.98TCr 2.71TCr 5.07TCr 3,47200Cr 5.09TCr 36TCr 14TCr 1,76500Cr 14TCr 13TCr 5,68000Cr P/E 2026 *
48.4x
P/E 2027 * 40.5x
Enterprise Value 3.61TCr 3.15TCr 2.97TCr 2.7TCr 5.05TCr 3,46100Cr 5.07TCr 36TCr 14TCr 1,76000Cr 14TCr 13TCr 5,66100Cr EV / Sales 2026 *
7.8x
EV / Sales 2027 * 7.16x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day-2.27%
1 week+16.07%
Current month+12.17%
1 month+16.89%
3 months+47.98%
6 months+89.29%
Current year+82.69%
1 week 202.82
Extreme 202.815
250.06
1 month 200.01
Extreme 200.01
250.06
Current year 112.65
Extreme 112.65
250.06
1 year 88
Extreme 88
250.06
3 years 68.7
Extreme 68.7
250.06
5 years 68.7
Extreme 68.7
442.54
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer - 01/02/2026
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Free

General Counsel

29,377 0.0195%
05/09/26 Tax

Chief Technology Officer

-408 0.0003%
04/09/26
Corvex Management LP
SellCompany -1,19,501 0.0791%
Change 5-day change 1-year change 3-year change Capi.($)
-2.27%+16.07%+133.21%+70.51% 3.62TCr
-1.04%+6.83%+35.84%+28.05% 24TCr
-0.32%+5.83%+9.58%-17.01% 15TCr
+2.55%+6.55%-10.35%+31.26% 14TCr
-0.48%+0.84%-55.70%-18.27% 6.28TCr
+0.01%+4.61%+18.61%+20.87% 5.09TCr
-1.69%-1.20%-19.89%-15.39% 4.82TCr
+0.08%+6.49%+23.87%+39.32% 4.41TCr
-1.88%+3.25%+40.14%+53.16% 4.14TCr
-1.50%+3.08%-17.64%+56.58% 3.22TCr
Average -0.65%+6.18%+15.77%+24.91% 8.45TCr
Weighted average by Cap. -0.31%+6.06%+14.30%+19.00%

Financials

2026 *2027 *
Net sales 462.4Cr 403.22Cr 380.73Cr 345.73Cr 647.76Cr 44TCr 650.46Cr 4.56TCr 1.76TCr 23TCr 1.74TCr 1.7TCr 73TCr 491.89Cr 428.93Cr 405.01Cr 367.78Cr 689.07Cr 47TCr 691.95Cr 4.85TCr 1.87TCr 24TCr 1.85TCr 1.81TCr 77TCr
Net income 77Cr 67Cr 64Cr 58Cr 108.17Cr 7.41TCr 108.63Cr 761.6Cr 293.9Cr 3.77TCr 290.08Cr 283.64Cr 12TCr 91Cr 79Cr 75Cr 68Cr 127.7Cr 8.75TCr 128.24Cr 899.11Cr 346.96Cr 4.45TCr 342.45Cr 334.85Cr 14TCr
Net Debt -12Cr -10Cr -9.52Cr -8.64Cr -16Cr -1.11TCr -16Cr -114.02Cr -44Cr -563.98Cr -43Cr -42Cr -1.81TCr -98Cr -85Cr -80Cr -73Cr -136.73Cr -9.37TCr -137.3Cr -962.65Cr -371.48Cr -4.76TCr -366.65Cr -358.51Cr -15TCr
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
18/26/18 $239.62 -2.27% 3,25,88,763
17/26/17 $245.18 +7.10% 36,77,035
16/26/16 $228.93 +2.99% 33,75,072
15/26/15 $222.29 +6.76% 31,48,966
14/26/14 $208.21 +0.85% 20,60,457
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
239.62USD
Average target price
202.65USD
Spread / Average Target
-15.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!